Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Buy

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Lipella Pharmaceuticals Inc. Common Stock (LIPO)

Pharmaceutical Preparations

https://www.lipella.com

Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's lead product candidates include LP-10 and LP-310.

400 N LEXINGTON ST, STE LL103
PITTSBURGH, PA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/20/2022

Market Cap

3,129,813

Shares Outstanding

5,800,000

Weighted SO

5,803,945

Total Employees

N/A

Upcoming Earnings

N/A

Beta

1.4621

Last Div

0.0000

Range

0.361-2.71

Chg

-0.0285

Avg Vol

3370740

Mkt Cap

3129813

Exch

NASDAQ

Country

US

Phone

412-894-1853

DCF Diff

0.6114

DCF

-0.2212

Div Yield

0.0000

P/S

0.0130

EV Multiple

-0.0021

P/FV

1.7454

Div Yield %

0.0000

P/E

-0.0032

PEG

-0.0003

Payout

0.0000

Current Ratio

4.3322

Quick Ratio

4.3322

Cash Ratio

2.4703

DSO

0.0536

DIO

0.0000

Op Cycle

0.0536

DPO

77.9264

CCC

-77.8729

Gross Margin

0.9965

Op Margin

-3.9688

Pretax Margin

-3.9101

Net Margin

-3.9101

Eff Tax Rate

0.0268

ROA

-430.9991

ROE

-390.9564

ROCE

-560.8015

NI/EBT

1.0000

EBT/EBIT

0.9852

EBIT/Rev

-3.9688

Debt Ratio

0.0429

D/E

0.0550

LT Debt/Cap

0.0000

Total Debt/Cap

0.0521

Int Coverage

87.9921

CF/Debt

-39.7811

Equity Multi

1.2819

Rec Turnover

6813.9002

Pay Turnover

4.6839

Inv Turnover

0.0000

FA Turnover

2330.9166

Asset Turnover

110.2273

OCF/Share

-0.4900

FCF/Share

-2.3878

Cash/Share

0.1560

OCF/Sales

-0.0155

FCF/OCF

4.8732

CF Coverage

-39.7811

ST Coverage

-39.7811

CapEx Coverage

-0.2582

Div&CapEx Cov

-0.2582

P/BV

1.7454

P/B

1.7454

P/S

0.0130

P/E

-0.0032

P/FCF

-0.1723

P/OCF

-0.7980

P/CF

-0.7980

PEG

-0.0003

P/S

0.0130

EV Multiple

-0.0021

P/FV

1.7454

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation